The Use of the GlideScope Ranger in Pediatric Critical Care Transport
| Tracking Information | |
|---|---|
| First Received Date ICMJE | January 21, 2010 |
| Last Updated Date | November 7, 2011 |
| Start Date ICMJE | July 2010 |
| Estimated Primary Completion Date | December 2011 (final data collection date for primary outcome measure) |
| Current Primary Outcome Measures ICMJE |
Number of attempts to successful intubation [ Time Frame: 30 days ] [ Designated as safety issue: Yes ] |
| Original Primary Outcome Measures ICMJE | Same as current |
| Change History | Complete list of historical versions of study NCT01054183 on ClinicalTrials.gov Archive Site |
| Current Secondary Outcome Measures ICMJE | Not Provided |
| Original Secondary Outcome Measures ICMJE | Not Provided |
| Current Other Outcome Measures ICMJE | Not Provided |
| Original Other Outcome Measures ICMJE | Not Provided |
| Descriptive Information | |
| Brief Title ICMJE | The Use of the GlideScope Ranger in Pediatric Critical Care Transport |
| Official Title ICMJE | The Use of the GlideScope Ranger in Pediatric Critical Care Transport |
| Brief Summary | This study seeks to assess the role of the GlideScope Ranger video laryngoscope in facilitating successful neonatal/pediatric intubation by pediatric critical care transport teams. The central hypothesis of this study is that the GlideScope Ranger video laryngoscope reduces the rates of failed intubation attempts by pediatric critical care transport teams. The aims of this project are designed to specifically: (1) Establish competencies for GlideScope Ranger video laryngoscopy-assisted intubation for pediatric and neonatal patients; and (2) Compare the intubation success rates for intubation using GlideScope Ranter video laryngoscopy and using conventional, direct laryngoscopy by pediatric and neonatal critical care transport teams. |
| Detailed Description | Not Provided |
| Study Type ICMJE | Interventional |
| Study Phase | Phase 4 |
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Condition ICMJE | Respiratory Failure |
| Intervention ICMJE |
|
| Study Arm (s) |
|
| Publications * |
|
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Enrolling by invitation |
| Estimated Enrollment ICMJE | 96 |
| Estimated Completion Date | June 2012 |
| Estimated Primary Completion Date | December 2011 (final data collection date for primary outcome measure) |
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
| Gender | Both |
| Ages | up to 17 Years |
| Accepts Healthy Volunteers | No |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | United States |
| Administrative Information | |
| NCT Number ICMJE | NCT01054183 |
| Other Study ID Numbers ICMJE | 090903 |
| Has Data Monitoring Committee | Yes |
| Responsible Party | Michael T. Bigham, MD, Akron Children's Hospital |
| Study Sponsor ICMJE | Akron Children's Hospital |
| Collaborators ICMJE | Not Provided |
| Investigators ICMJE | Not Provided |
| Information Provided By | Akron Children's Hospital |
| Verification Date | November 2011 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|